CYCLERION THERAPEUTICS, INC. (KRSA) Operating margin 2019–2025
CYCLERION THERAPEUTICS, INC. (KRSA) operating margin by fiscal year — reported operating income divided by reported revenue.
-239.8%FY2025 · since FY2019: -2774.3% → -239.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -239.8% | -58.4 pp |
| FY2024 | -181.4% | — |
| FY2022 | -6242.4% | -4842.2 pp |
| FY2021 | -1400.2% | +2139.2 pp |
| FY2020 | -3539.4% | -765.1 pp |
| FY2019 | -2774.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net incomeKRSA Net marginKRSA Gross profitKRSA Gross marginKRSA Operating incomeKRSA Operating cash flowKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total assetsKRSA Total liabilitiesKRSA Shareholders’ equityKRSA overview →